Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$481,600
-$80,000 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,779
of 2,821 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. PFE ranks #4 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
This page
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $481,600 | 20,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $561,600 | 20,000 | Shares | Sole | 2026-06-04 | |
| 2024-12-31 | $618,016 | 23,295 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $748,677 | 25,870 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $732,236 | 26,170 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $771,450 | 27,800 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $802,665 | 27,880 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $1,063,927 | 32,075 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $1,370,915 | 37,375 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $1,737,060 | 42,575 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $2,248,155 | 43,875 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $2,075,755 | 47,435 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $3,292,708 | 62,802 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,757,932 | 72,589 | Shares | Sole | 2022-05-24 | |
| 2021-12-31 | $5,810,283 | 98,396 | Shares | Sole | 2022-05-23 | |
| 2021-09-30 | $4,725,766 | 109,876 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $4,213,655 | 107,601 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $3,817,953 | 105,381 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $3,861,589 | 104,906 | Shares | Sole | 2022-03-08 | |
| 2020-09-30 | $1,888,652 | 51,462 | Shares | Sole | 2022-05-06 | |
| 2020-06-30 | $1,682,088 | 51,440 | Shares | Sole | 2022-05-06 | |
| 2020-03-31 | $1,397,610 | 42,819 | Shares | Sole | 2020-06-12 | |
| No filing history on record for this holder in this stock. | ||||||